Prot# ACZ EGFR 01: A Phase II, Rand, Dbl-Blind, Parallel Design Stdy to Eval ACZONE (dapsone) Gel, 5% As a Trmt for Rash Related to the Human Epidermal Growth Factor Receptor1 (HER1) /Epidermal-Growth-Factor-Receptor(EGFR) Inhibitor Tarceva® (erlotinib)

  • Patel, Jyoti D (Co-PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/8/079/30/07

Funding

  • QLT USA, Inc. (ACZ EGFR 01)